<--- Back to Details
First PageDocument Content
Microbiology / Latent tuberculosis / QuantiFERON / Tuberculosis treatment / Extensively drug-resistant tuberculosis / Isoniazid / Mantoux test / Multi-drug-resistant tuberculosis / Rifabutin / Tuberculosis / Medicine / Health
Date: 2014-12-24 13:25:50
Microbiology
Latent tuberculosis
QuantiFERON
Tuberculosis treatment
Extensively drug-resistant tuberculosis
Isoniazid
Mantoux test
Multi-drug-resistant tuberculosis
Rifabutin
Tuberculosis
Medicine
Health

Self-Study Modules on Tuberculosis Treatment of Latent

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 829,72 KB

Share Document on Facebook

Similar Documents

Tuberculosis / Latent tuberculosis / Tuberculosis diagnosis / Tuberculosis management / GeneXpert MTB/RIF / Multi-drug-resistant tuberculosis / Mantoux test / QuantiFERON / Isoniazid / BCG vaccine / DOTS / Rifabutin

DOC Document

DocID: 1oTAj - View Document

Tuberculosis / Health / Medicine / Clinical medicine / Colorado State University / Bedaquiline / Middle East respiratory syndrome coronavirus / Camel / Rifabutin

301030_dec14-CSUmatters_113.indd

DocID: 1mhll - View Document

Chemistry / Extensively drug-resistant tuberculosis / Tuberculosis treatment / Antiretroviral drug / AIDS / Rifabutin / Efavirenz / Nevirapine / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Health

ISTC Training Modules 2008 TB and HIV Infection: Treatment Slide 1

DocID: 15wzp - View Document

Microbiology / Extensively drug-resistant tuberculosis / Tuberculosis treatment / Multi-drug-resistant tuberculosis / QuantiFERON / AIDS / Antiretroviral drug / Latent tuberculosis / Rifabutin / Tuberculosis / Medicine / Health

PDF Document

DocID: 15hUx - View Document

Health / Tuberculosis treatment / Multi-drug-resistant tuberculosis / Extensively drug-resistant tuberculosis / Rifampicin / Pyrazinamide / Mycobacterium tuberculosis / Rifabutin / Isoniazid / Tuberculosis / Medicine / Bacteria

Research articles Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011 C Ruesen ()1, A B van Gageldonk-Lafeber1, G de Vries1,2, C G Erkens2, J van Rest1,2, H

DocID: 14xv0 - View Document